Drug Discovery

© Getty Images

Danaher acquires Abcam shares in deal worth $5.7BN

By Liza Laws

Danaher is to acquire Abcam for $24 per share - a total enterprise value of approximately $5.7 billion representing approximately 40% more than Abcam's undisclosed share prices in May.

© Getty Images

Relation Therapeutics opens flagship lab in London

By Liza Laws

The company is using a ‘lab-in-the-loop’ process to advance the drug discovery process, and stated that opening a new lab space represents a step forward on its path to ‘transform drug discovery’.


Follow us


View more


Featured Suppliers